Protein analysis in cerebrospinal fluid: II. Reference values derived from healthy individuals 18-88 years of age

European Neurology

Volumn 33, Issue 2, 1993, Pages 129-133

  Blennow, Kaj ^a   Fredman, Pain ^a   Wallin, Anders ^a   Gottfries, Carl Gerhard ^a   Karlsson, Ingvar ^a   Langs Troin, Goran ^a   Skoog, Ingmar ^b   Svennerholm, Lars ^a   Wikkelsö, Carsten ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Psychiatry ^*  (Sweden)

Author keywords

Blood cerebrospinal fluid barrier; Cerebrospinal fluid; CSF S albumin ratio; Immunoglobulin G index; Immunoglobulins; Intrathecal synthesis

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROSPINAL FLUID ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN PRODUCTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; REFERENCE VALUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMAN; IMMUNOGLOBULIN G; MALE; MIDDLE AGE; REFERENCE VALUES; SERUM ALBUMIN; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T;

EID: 0027503277     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000116919     Document Type: Article

References (22)

1. Davson H: The cerebrospinal fluid: in Lajlha A (ed): Handbook of Neurochemistry. New York. Plenum Press. 1969. pp 23-48.
2. Fishman RA: Cerebrospinal fluid in diseases of Ihe nervous system. Philadelphia. Saunders. 1980.
3. Ganrol K, Laurell CB: Measurement of IgG and albumin content of cerebrospinal fluid. and its interpretation. Clin Chem 1974:20: 571-573.
4. Tibbling G, Link H, Ohman S: Principles of albumin and IgG analyses in neurological disorders. 1. Establishment of reference values. Scand J Clin Lab Invest 1977:37:385-390.
5. Delpech B, Lichtblau E: Etude quantitative des immunoglobulines G el de I'albuminc du li-quide cephalo-rachidien. Clin Chim Acta 1972: 37:15-23.
6. Tourtellotte WW: What is multiple sclerosis? Laboratory criteria for diagnosis; in Davison AN. Humpfrey JH. Liversledge AL. et al eds: Multiple Sclerosis Research. New York. Elsevier. 1975. pp 9-26.
7. Schuller E, Sagar HJ: Local synthesis of CSF immunoglobulins: A neuroimmunological classification. J Neurol Sci 1981:51:361-370.
8. Schuller E, Sagar HJ: Central nervous system IgG synthesis in multiple selerosis: Application of a new formula. Acta Neurol Scand 1983:67: 365-371.
9. Reiber H, Felgenhauer K: Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987:163:319-328.
10. Blennow K, Fredman P, Wallin A: Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production. Eur Neurol 1993:33:134-142.
11. Ahonen A, Myllyla VV, Hokkanen E: Measurement of reference values for certain proteins in cerebrospinal fluid. Acta Neurol Scand 1978: 57:358-365.
12. Breebaart K, Becker H, Jongebloed FA: Investigation of reference values of components of cerebrospinal fluid. J Clin Chem Clin Bioehcm 1978:16:561-565.
13. Folstein M, Folstein S, McHugh P: "Mini-Mental Stale" a practical method for grading the cognitive stale of patients for the clinician. J PsychiatrRes 1975:12:189-198.
14. Blennow K, Fredman P, Wallin A: Protein analysis in cerebrospinal fluid. 1. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. Eur Neurol 1993:33:126-128.
15. Fredman P: Detection ol'oligoclonal IgG bands in cerebrospinal fluid by immunofixation after isolectric focusing on polyacrylamide gels with the PhastSysiem™. Electrophoresis, in press.
16. Laurell CB: Elcctroimmunoassay. Scand J Clin Lab Invest 1972:28 (suppl l24):2l-37.
17. International Federation of Clinical Chemistry IFCC: Approved recommendation (1987) on the theory of reference values. 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1987:170:13-32.
18. Merritt H, Fremont-Smith F: The cerebrospinal fluid. Philadelphia. Saunders. 1937.
19. Weisncr B, Bernhardt W: Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. J Neurol Sci 1978:37:205-214.
20. Ahlberg J, Blomstrand C, Ronquist G, Wik-kelso C: Dementia and adenylate kinase activity in cerebrospinal fluid. Acta Neurol Scand 1985:72:525-527.
21. May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI: Cerebrospinal fluid production is reduced in healthy aging. Neurology 1990:40:500-503.
22. Mooradian AD: Effect of aging on the blood-brain barrier. Neurobiol Aging 1988:9:31-39.